None of the combination-specific risks have been characterized in a human trial because that trial does not exist
The results were quite impressive, showing a significant improvement in insulin sensitivity, a decrease in their levels of LDLs, often called the bad cholesterol, a lower BMI, and an increase in their levels of HDLs, often referred to as the good cholesterol (1)
NAD+ Nicotinamide adenine dinucleotide supports cellular energy production, metabolism, and recovery
surrogate endpoints (weight, HbA1c) are not hard outcomes
Customized protocols may combine topical and injectable GHK-Cu delivery methods with complementary treatments such as platelet-rich plasma , microneedling , prescription medication( such as Minoxidil) , and nutritional optimization